A Pilot Trial Examining the Merits of Combining Amantadine and Repetitive Transcranial Magnetic Stimulation as an Intervention for Persons With Disordered Consciousness After TBI
Guardado en:
Autores principales: | Sandra Kletzel, Theresa Bender Pape, Amy Herrold, Sherri Livengood, Ann Guernon, Todd Parrish, Trudy Mallinson, james higgins, Joshua Rosenow, Dulal Bhaumik |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3f2dbe09e634bd38a609980b49ed29f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Customizing rTMS treatment targeting for co-occurring alcohol use disorder and mild traumatic brain injury using multi-modal neuroimaging data as neurobiological markers
por: Amy Herrold, et al.
Publicado: (2021) -
Preliminary evaluation of the clinical utility of miRNA as neurobiological markers of TBI diagnosis and rTMS treatment responsiveness
por: Theresa Bender Pape
Publicado: (2021) -
Clinical and genetic investigation of amantadine-associated corneal edema
por: Hessen MM, et al.
Publicado: (2018) -
Precision targeting of brain networks in TBI
por: Shan Siddiqi
Publicado: (2021) -
Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells
por: Po-Yen Lee, et al.
Publicado: (2021)